NVIDIA (NVDA) and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery. The co-innovation lab ...

Nvidia Corp (NASDAQ: NVDA) and Eli Lilly and Co (NYSE: LLY) are launching a lab designed to apply advanced artificial intelligence to drug development. The collaboration will combine Lilly's expertise ...

Eli Lilly (NYSE:LLY) and Samsung Biologics have agreed to launch a Gateway Labs partnership in Korea. The collaboration will ...

Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...

Eli Lilly and Nvidia will launch a co-innovation AI lab to accelerate drug discovery. The companies will jointly invest up to $1 billion over five years to support the lab, which is based in the Bay ...

Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact the technology sector. Nvidia (NVDA) and Eli Lilly (LLY) said they're investing up to $1B over five years to develop ...

On the surface, the two companies don't seem as if they'd have much in common. Both benefit from advancing medical technology using AI, however. 10 stocks we like better than Nvidia › In a corporate ...

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced a ...

South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has announced a collaboration ...